These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2092442)

  • 1. [Validity of immunohistologic study techniques in lung cancers].
    Dämmrich J
    Verh Dtsch Ges Inn Med; 1990; 96():208-20. PubMed ID: 2092442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential lung cancer diagnosis--progress or fiasco?].
    Müller KM
    Fortschr Med; 1990 Apr; 108(11):17-9. PubMed ID: 2162802
    [No Abstract]   [Full Text] [Related]  

  • 3. Applied histochemistry and cytochemistry.
    Eckert H
    Z Erkr Atmungsorgane; 1991; 176(2-3):122-7. PubMed ID: 1858411
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary osteosarcoma of the lung. A reappraisal following immunohistologic study.
    Colby TV; Bilbao JE; Battifora H; Unni KK
    Arch Pathol Lab Med; 1989 Oct; 113(10):1147-50. PubMed ID: 2802944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alveolar cell adenoma. A newly defined benign lung tumor].
    Siebenmann RE; Odermatt B; Hegglin J; Binswanger RO
    Pathologe; 1990 Jan; 11(1):48-54. PubMed ID: 2179944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
    Eberlein-Gonska M; Wiedenmann B; Waldherr R
    Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
    Iwakiri S; Nagai S; Katakura H; Takenaka K; Date H; Wada H; Tanaka F
    Ann Surg Oncol; 2009 Jun; 16(6):1678-85. PubMed ID: 19330380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chondrosarcoma of lung: case report and review of literature.
    Shukla K; Jetly D; Parikh B; Shah B; Patel N; Mehta H; Panchal H
    Indian J Pathol Microbiol; 2006 Oct; 49(4):570-3. PubMed ID: 17183859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary melanoma diagnosis: the role of immunohistochemistry and immunocytochemistry.
    Kotoulas C; Skagias L; Konstantinou G; Tsilalis T; Tsintiris K; Laoutidis G; Sambaziotis D
    J BUON; 2007; 12(4):543-5. PubMed ID: 18067215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis?
    Sands TJ; Soomro IN; Chaudry ZR; Ronan J
    Histopathology; 2006 Dec; 49(6):653-4. PubMed ID: 17163851
    [No Abstract]   [Full Text] [Related]  

  • 12. [New biological markers of lung cancer: toward targeted biotherapies?].
    Zalcman G; Urban T
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):549-51. PubMed ID: 12473938
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary neuroendocrine neoplasia: from molecular biology to the clinic, by way of immunohistochemistry].
    Barbareschi M; Doglioni C
    Pathologica; 1998 Feb; 90(1):51-3. PubMed ID: 9628981
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of prostatic adenocarcinoma with pulmonary metastases--diagnosis by transbronchial lung biopsy and immunohistochemistry].
    Nishi K; Amemiya T; Ooka T; Kurumaya H; Fujimaru M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):1001-5. PubMed ID: 7531254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Solitary epithelioid hemangioendothelioma, a rare vascular tumor of the lung].
    Buchenroth M; Beus J; Bittinger F; Kelbel C; Kersjes W; Mayer E; Ferlinz R
    Pneumologie; 1995 Mar; 49(3):239-42. PubMed ID: 7753772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor-associated prognostic parameters in non-small-cell bronchial carcinoma].
    Thomas M
    Pneumologie; 1997 Jul; 51(7):669-77. PubMed ID: 9333800
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue.
    Joshi MB; D'Amico TA; Harpole DH
    Methods Mol Med; 2003; 75():369-88. PubMed ID: 12407753
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic PEComa to the brain.
    Parfitt JR; Keith JL; Megyesi JF; Ang LC
    Acta Neuropathol; 2006 Sep; 112(3):349-51. PubMed ID: 16845532
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
    Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pulmonary rhabdomyosarcoma diagnosed by fine-needle aspiration cytology.
    Gray JA; Nguyen GK
    Diagn Cytopathol; 2003 Sep; 29(3):181-2. PubMed ID: 12951690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.